A new CAR-T is credited with a 'surprising' impact in tiny study of advanced liver cancer — raising hopes on solid tumors
A tiny study has provided the first glimmer of hope that Eureka Therapeutics’ CAR-T therapy may work in solid tumors.
In a proof-of-concept study involving …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.